Could psychedelic therapy have a place in end-of-life care? We asked doctors

Doctors in palliative care are increasingly intrigued by the potential of psychedelic therapy to offer relief for patients facing terminal illnesses, noting its promise in easing psychological distress and improving overall well-being. Despite this interest, they emphasize that much research is still needed to understand the long-term effects and safety of such treatments. This exploration is significant as it could revolutionize end-of-life care, offering new avenues for mental health support and potentially improving the quality of life for patients in their final stages. The debate underscores the need for rigorous clinical trials and ethical considerations as psychedelic therapy edges closer to clinical practice.